Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control.
Leonardo LimaMateus BerniJamile MotaDaniel BressanAlison JulioRobson CavalcanteVanessa MaciasZhiqian LiJason L RasgonEthan BierHelena Marcolla AraujoPublished in: The CRISPR journal (2024)
Rhodnius prolixus is currently the model vector of choice for studying Chagas disease transmission, a debilitating disease caused by Trypanosoma cruzi parasites. However, transgenesis and gene editing protocols to advance the field are still lacking. Here, we tested protocols for the maternal delivery of CRISPR-Cas9 (clustered regularly spaced palindromic repeats/Cas-9 associated) elements to developing R. prolixus oocytes and strategies for the identification of insertions and deletions (indels) in target loci of resulting gene-edited generation zero (G0) nymphs. We demonstrate successful gene editing of the eye color markers Rp-scarlet and Rp-white , and the cuticle color marker Rp-yellow, with highest effectiveness obtained using Receptor-Mediated Ovary Transduction of Cargo (ReMOT Control) with the ovary-targeting BtKV ligand. These results provide proof of concepts for generating somatic mutations in R. prolixus and potentially for generating germ line-edited lines in triatomines, laying the foundation for gene editing protocols that could lead to the development of novel control strategies for vectors of Chagas disease.
Keyphrases
- crispr cas
- genome editing
- trypanosoma cruzi
- genome wide
- randomized controlled trial
- systematic review
- copy number
- pregnant women
- gene expression
- dna methylation
- body mass index
- cancer therapy
- drug delivery
- physical activity
- weight gain
- birth weight
- pregnancy outcomes
- weight loss
- transcription factor
- genome wide association study